Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more, the Wall Street Journal reported. The companies are discussing a...
Brazilian pharma Hypera in merger talks with Grupo NC – media report
Brazilian drugmaker Hypera SA is in talks to merge with conglomerate Grupo NC, according to a Tuesday report from business newspaper Valor Economico. Under the potential deal, Hypera would become part of Grupo NC, which...
Walgreens defers Boots UK sale; Reliance to look for other opportunities
American retail major Walgreens Boots Alliance on Tuesday said it would retain its pharma retail business — Boots UK — thus abandoning the entire sale process. The company did not make any comment specifically on the...
Glenmark Pharma’s US arm acquires four OTC drugs from Wockhardt
Glenmark Pharmaceuticals Ltd. said its US subsidiary has acquired generic versions of four over-the-counter drugs from Wockhardt Ltd. The acquisition includes approved Abbreviated New Drug Applications (ANDAs) for...
Cipla buys additional stake in digital health company GoApptiv
Drugmaker Cipla said that it has agreed to acquire an additional stake in digital tech company GoApptiv for Rs 25.90 crore. Post completion of the deal, Cipla’s total stake in GoApptiv will increase to 22.02% on a fully...
RIL in talks to raise up to $8 bn for Boots deal
Reliance Industries Ltd (RIL) is in talks with a clutch of global banks to raise $8 billion for its planned leveraged buyout of British pharma chain Boots, two people aware of the discussions said. The conglomerate, led...
DRL acquires injectable portfolio from US-based Eton Pharma for $50 million
Dr. Reddy’s announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois, based Eton Pharmaceuticals. Under the terms of the agreement, Dr. Reddy’s will pay $5 million...
Dr Reddy’s Laboratories planning mergers and acquisitions to climb up ladder
Dr Reddy’s Laboratories said it aims to be among the top five drugmakers in India, largely driven by mergers and acquisitions (M&A) of brands, companies and in-licensing deals targeting chronic categories...
RIL, Apollo put in binding bid to acquire UK pharmacy chain Boots
A consortium of Apollo Global Management and Reliance Industries has made a binding offer for Walgreens Boots Alliance’s international arm, people with knowledge of the matter said. The investor group submitted a bid...
Mukesh Ambani and Apollo close in on Boots buyout
Mukesh Ambani-owned Reliance Industries and US buyout firm Apollo Global Management are moving ahead to make a firm offer for Walgreens Boots Alliance Inc’s international chemist and drugstore units, known as...
Creador, India Life Sciences Fund buy into Accumax Lab
Private equity firms Creador and India Life Sciences Fund have invested $68 mn (Rs520 crore) in Ahmedabad-based Accumax Lab Devices, an export-focused manufacturer of laboratory consumables and benchtop equipment...
Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania
Sun Pharma said that its subsidiary – S.C. Terapia has acquired the Uractiv portfolio from Fiterman Pharma in Romania for an undisclosed amount. The Uractiv portfolio comprises food supplements including minerals...
